405 related articles for article (PubMed ID: 22099870)
1. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T
Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870
[TBL] [Abstract][Full Text] [Related]
2. [Effect of transjugular portosystemic shunt on insulin resistance].
Stefánková J; Safka V; Fejfar T; Hůlek P; Dresslerová I; Krajina A
Vnitr Lek; 2002 Nov; 48(11):1017-24. PubMed ID: 12577452
[TBL] [Abstract][Full Text] [Related]
3. Insulin sensitivity and body composition in cirrhosis: changes after TIPS.
Holland-Fischer P; Nielsen MF; Vilstrup H; Tønner-Nielsen D; Mengel A; Schmitz O; Grønbaek H
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G486-93. PubMed ID: 20489042
[TBL] [Abstract][Full Text] [Related]
4. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study.
Lafortune M; Martinet JP; Denys A; Patriquin H; Dauzat M; Dufresne MP; Colombato L; Pomier-Layrargues G
AJR Am J Roentgenol; 1995 Apr; 164(4):997-1002. PubMed ID: 7726065
[TBL] [Abstract][Full Text] [Related]
5. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
6. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
[TBL] [Abstract][Full Text] [Related]
7. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
[TBL] [Abstract][Full Text] [Related]
8. Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow.
Iversen P; Keiding S; Mouridsen K; Ott P; Vilstrup H
Clin Gastroenterol Hepatol; 2011 Nov; 9(11):1001-3. PubMed ID: 21806953
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
Lotterer E; Wengert A; Fleig WE
Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
[TBL] [Abstract][Full Text] [Related]
10. Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS).
Raddatz D; Rossbach C; Buchwald A; Scholz KH; Ramadori G; Nolte W
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):268-74. PubMed ID: 15926112
[TBL] [Abstract][Full Text] [Related]
11. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
[TBL] [Abstract][Full Text] [Related]
12. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial.
Rosemurgy AS; Frohman HA; Teta AF; Luberice K; Ross SB
J Am Coll Surg; 2012 Apr; 214(4):445-53; discussion 453-5. PubMed ID: 22463885
[TBL] [Abstract][Full Text] [Related]
13. [Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
Han GH; Meng XJ; Yin ZX; Wang JH; He CY; Liang J; Guo XG; Liu J; Ding L; Wu KC; Fan DM
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1549-52. PubMed ID: 19953883
[TBL] [Abstract][Full Text] [Related]
14. Hepatic and splanchnic perfusion and oxygenation after transjugular intrahepatic portosystemic shunt.
Cervera M; Añón R; Palmero J; Martínez J; Garcés R; Ripollés T; Moreno-Osset E; Alamán G; Antón M
Rev Esp Enferm Dig; 2000 Apr; 92(4):199-210. PubMed ID: 10867409
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
[TBL] [Abstract][Full Text] [Related]
16. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation.
King A; Masterton G; Gunson B; Olliff S; Redhead D; Mangat K; Oniscu G; Hayes P; Tripathi D
Liver Transpl; 2011 Jul; 17(7):771-8. PubMed ID: 21714062
[TBL] [Abstract][Full Text] [Related]
17. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
[TBL] [Abstract][Full Text] [Related]
18. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
[TBL] [Abstract][Full Text] [Related]
19. [Clinical application of the transjugular intrahepatic portosystemic stent-shunt in the emergency treatment of esophagogastric varices bleeding due to cirrhosis].
You LY; Li YC; Yan D; Xu Y; Yang J; Yang LH; Cheng F; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):490-3. PubMed ID: 22152237
[TBL] [Abstract][Full Text] [Related]
20. Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature.
Dasarathy J; Alkhouri N; Dasarathy S
Liver Int; 2011 Oct; 31(9):1250-8. PubMed ID: 21745273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
